Other Science
480 articles
Juan Pellerano-Rendon
Juan Manuel Pellerano-Rendon IV is a first-generation American of Dominican and Colombian descent. He received his degree in Advertising, Marketing, and Sport Administration from the University of Miami. In his career, Juan has focused on the marketing and tech sectors, having worked at multiple advertising agencies and tech startups. He currently is an account director at […]
Millicent Fortunoff
Millicent Fortunoff is President of M. Fortunoff Communications. She has extensive experience managing global and national media relations campaigns that build one reputation across regions, yet tailored to local issues and audiences. Prior to opening her own consultancy Ms. Fortunoff was a Senior Vice President in the Global Issues Communications Group at Ruder Finn (Finn […]
Exploring the Effectiveness of an Experimental Class of Drug
Does adding a PARP inhibitor drug to standard treatment help control the spread of advanced pancreatic cancer in patients with the BRCA mutation?
A New Chemotherapy and Radiation Regimen to Shrink Tumors Before Surgery
Researchers are testing a new combination of chemotherapies and radiation to shrink pancreatic cancer tumors and make surgical removal possible.
High-Dose Focused Radiation after Surgical Removal of Pancreatic Tumors
A clinical trial looks at the effectiveness of stereotactic body radiation therapy in killing cancer cells in the margins after pancreatic tumor removal.
Using a Vitamin to Make Low-Dose Chemotherapy More Effective
A clinical trial compares the effectiveness of low-dose continuous chemotherapy with and without high doses of vitamin C.
Testing Targeted Immunotherapy Against Pancreatic Cancer
Targeted immunotherapy is the focus of a clinical trial that tests the drug ibrutinib, approved for leukemia treatment, against pancreatic cancer.